Article Details

Ysios Capital Invests in Engrail Therapeutics $157M Series B - Born2Invest

Retrieved on: 2024-03-20 18:31:35

Tags for this article:

Click the tags to see associated articles and topics

Ysios Capital Invests in Engrail Therapeutics $157M Series B - Born2Invest. View article details on hiswai:

Excerpt

In this way, Ysios Capital has joined a syndicate of investors led by F-Prime Capital, Forbion and Norwest Venture Partners , with additional ...

Article found on: born2invest.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo